Amcare Medical And Research Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
as on 17-11-2024
- Paid Up Capital ₹ 2.61 Cr
as on 17-11-2024
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.31 Cr
as on 17-11-2024
- Satisfied Charges ₹ 11.97 Cr
as on 17-11-2024
- Revenue -8.60%
(FY 2023)
- Profit 5.00%
(FY 2023)
- Ebitda -15.19%
(FY 2023)
- Net Worth 53.15%
(FY 2023)
- Total Assets -5.92%
(FY 2023)
About Amcare Medical And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 2.61 Cr.
The company currently has active open charges totaling ₹4.31 Cr. The company has closed loans amounting to ₹11.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Nibber, Mandeep Nibber, and Abhitej Nibber serve as directors at the Company.
- CIN/LLPIN
U85110PB2003PTC055356
- Company No.
025735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Patiala, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Amcare Medical And Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Nibber  | Director | 23-Jan-2003 | Current |
| Mandeep Nibber | Director | 23-Jan-2003 | Current |
| Abhitej Nibber | Director | 22-Jun-2016 | Current |
Financial Performance of Amcare Medical And Research.
Amcare Medical And Research Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.6% decrease. The company also saw a slight improvement in profitability, with a 5% increase in profit. The company's net worth Soared by an impressive increase of 53.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amcare Medical And Research?
In 2023, Amcare Medical And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Amcare Health India FoundationActive 1 year 7 monthsMandeep Nibber and Abhitej Nibber are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Sep 2021 | ₹4.00 Cr | Open |
Others Creation Date: 09 Jun 2020 | ₹0.42 M | Open |
Others Creation Date: 09 Jun 2020 | ₹2.70 M | Open |
How Many Employees Work at Amcare Medical And Research?
Amcare Medical And Research has a workforce of 18 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amcare Medical And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amcare Medical And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
